Accession Number: | 0001062993-21-002791 |
Date: | 2021-03-16 |
Issuer: | BRICKELL BIOTECH, INC. (BBI) |
Original Submission Date: |
CHADHA DEEPAK
C/O BRICKELL BIOTECH, INC.
5777 CENTRAL AVENUE, SUITE 102
BOULDER, CO 80301
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-03-16 | M | 25,000 | a | $0.00 | 71,717 | direct | ||
COMMON STOCK | 2021-03-16 | F | 8,750 | d | $1.14 | 62,967 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2021-03-16 | deemed execution date | M | 25,000 (d) | common stock 25,000 | $0.00 | 0 | direct |
ID | footnote |
---|---|
f1 | restricted stock units ("rsus") converted into common stock on a one-for-one basis. |
f2 | represents shares withheld to satisfy tax withholding obligations upon the vesting of rsus. |
f3 | these rsus vested in full on march 16, 2021. |